Christopher Haqq Insider Trading for February 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Christopher Haqq.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Christopher Haqq for February 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 16 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Option Exercise | M | 0.00 | 829 | 0 | 3,040 | |
| Feb 16 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 15.49 | 7,604 | 117,786 | 392,855 | 400.5 K to 392.9 K (-1.90 %) |
| Feb 16 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Buy | M | 0.00 | 829 | 0 | 400,459 | 399.6 K to 400.5 K (+0.21 %) |
| Feb 10 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 15.46 | 13,975 | 216,054 | 399,630 | 413.6 K to 399.6 K (-3.38 %) |
| Feb 08 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Grant | A | 0.00 | 49,500 | 0 | 413,605 | 364.1 K to 413.6 K (+13.59 %) |